Cargando…
Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
BACKGROUND: Pathological response to neoadjuvant treatment for patients with high-grade serous ovarian carcinoma (HGSOC) is assessed using the chemotherapy response score (CRS) for omental tumor deposits. The main limitation of CRS is that it requires surgical sampling after initial neoadjuvant chem...
Autores principales: | Rundo, Leonardo, Beer, Lucian, Escudero Sanchez, Lorena, Crispin-Ortuzar, Mireia, Reinius, Marika, McCague, Cathal, Sahin, Hilal, Bura, Vlad, Pintican, Roxana, Zerunian, Marta, Ursprung, Stephan, Allajbeu, Iris, Addley, Helen, Martin-Gonzalez, Paula, Buddenkotte, Thomas, Singh, Naveena, Sahdev, Anju, Funingana, Ionut-Gabriel, Jimenez-Linan, Mercedes, Markowetz, Florian, Brenton, James D., Sala, Evis, Woitek, Ramona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243357/ https://www.ncbi.nlm.nih.gov/pubmed/35785153 http://dx.doi.org/10.3389/fonc.2022.868265 |
Ejemplares similares
-
Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
por: Crispin-Ortuzar, Mireia, et al.
Publicado: (2023) -
Lesion-specific 3D-printed moulds for image-guided tissue multi-sampling of ovarian tumours: A prospective pilot study
por: Delgado-Ortet, Maria, et al.
Publicado: (2023) -
Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer
por: Martin-Gonzalez, Paula, et al.
Publicado: (2020) -
Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancer
por: Beer, Lucian, et al.
Publicado: (2020) -
Radiomic and Volumetric Measurements as Clinical Trial Endpoints—A Comprehensive Review
por: Funingana, Ionut-Gabriel, et al.
Publicado: (2022)